Cargando…
Patients’ Experience of Systemic Treatment of Hepatocellular Carcinoma: A Review of the Impact on Quality of Life
SIMPLE SUMMARY: Hepatocellular carcinoma remains a serious disease for which curative treatment is only available for about 20% of patients. Because of the severity of the disease and the modest benefit of treatment, quality of life is of paramount importance, especially as its impact on the prognos...
Autores principales: | Muzellec, Léa, Bourien, Héloïse, Edeline, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749998/ https://www.ncbi.nlm.nih.gov/pubmed/35008343 http://dx.doi.org/10.3390/cancers14010179 |
Ejemplares similares
-
Tivozanib for hepatocellular carcinoma: not likely a new option
por: Estrade, Florian, et al.
Publicado: (2020) -
ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular Carcinoma
por: Lescure, Céline, et al.
Publicado: (2021) -
Locoregional Treatment in Intrahepatic Cholangiocarcinoma: Which Treatment for Which Patient?
por: Bourien, Héloïse, et al.
Publicado: (2023) -
Hepatocellular carcinoma in elderly patients: challenges and solutions
por: Brunot, Angélique, et al.
Publicado: (2016) -
Hepatocellular carcinoma and its impact on quality of life: A review of the qualitative literature
por: Norman, Eleanor M. L., et al.
Publicado: (2022)